TORONTO, March 15, 2018 (GLOBE NEWSWIRE) --
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES.
Bradmer Pharmaceuticals Inc. (“Bradmer”) (TSX VENTURE:BMR.H), Galaxy Digital LP (“Galaxy Digital”) and First Coin Capital Corp. (“First Coin”) report an update to the terms of the plan of arrangement (the “Arrangement”) and concurrent subscription receipt financing (the “Offering”), both as announced on February 14, 2018.
The Arrangement will constitute a reverse takeover of Bradmer by Galaxy Digital and First Coin pursuant to the policies of the TSX Venture Exchange (the “TSXV”) and the reactivation of the listing of Bradmer, which is currently a NEX-listed issuer.
The parties have submitted initial materials, including a draft management information circular in respect of the proposed Arrangement, to the TSXV. The TSXV is currently in the process of reviewing these materials and its review is ongoing. As announced on February 14, 2018, a meeting of the shareholders of Bradmer will be called to approve the Arrangement and other matters related to the Arrangement. It is anticipated that Bradmer will be in a position to announce its meeting date shortly. Further details will be provided when available.
See the press release of Bradmer dated February 14, 2018 for further information concerning the Arrangement and concurrent subscription receipt financing.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For additional information, please contact:
Paul Van Damme, Chief Financial Officer
Fiona Choi, Director of Corporate Communications
Frans Tjallingii, Chief Executive Officer
Source:Bradmer Pharmaceuticals Inc.